Abu Dhabi launches life sciences cluster to drive healthcare innovation globally, tapping into $25.3 trillion market

Abu Dhabi firm G42 to use locals’ DNA for medical AI

The NewsAbu Dhabi is looking to leverage more than 800,000 DNA samples its artificial intelligence firm G42 has gathered from the local population to build an AI model for developing new drugs and offering precision medicine. This futuristic vision, put forward by G42 CEO Peng Xiao, is part of broader ambitions by the UAE to become a life sciences hub.The UAE capital is courting big pharma, people familiar with the matter told Semafor, including…

Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week

Establishing actionable frameworks to advance precision medicine and longevity science The declaration highlights the impact longevity and precision medicine can have on supporting healthy communities, and engages leaders to work towards actionable solutions, drive consensus among global peers, and invest in long-term solutions It brings together leading healthcare and academic institutions to redefine and improve […]

Latest News Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week - Businessfortnight

Establishing actionable frameworks to advance precision medicine and longevity science The declaration highlights the impact longevity and precision medicine can have on supporting healthy communities, and engages leaders to work towards actionable solutions, drive consensus among global peers, and invest in long-term solutions It brings together leading healthcare and academic institutions to redefine and improve health outcomes while aligning …

Innovation with GenAI: Lessons from Life Sciences and Beyond

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.